by Elizabeth Kissling | Aug 30, 2010 | Advertising, Menopause, New Research, Pharmaceutical
Longtime readers may recall that late last year, the New York Times published an essay about how hard Big Pharma has worked to market menopause as an estrogen deficiency disease. Despite that exposé and others of the well-documented risks and limited benefits of...